Estructura del grupo
12 empresas en 3 países
Cargando…
12 empresas en 3 países
Una cuenta gratuita para las apps de Prognia: Ward para estudiar, Osler para respuestas clínicas con sus fuentes y la red para encontrar a tus colegas.
Prognia forma los grupos a partir de los nombres que publican las autoridades reguladoras y de los vínculos entre empresas; no son una estructura societaria oficial.
Todos los medicamentos de todas las empresas del grupo, primero los vigentes.
1–25 de 222
| Medicamento | Principio activo | País | Estado | Autorización |
|---|---|---|---|---|
| 8-MOP10mg · Capsule | Methoxsalen | Estados Unidos | No comercializado | 1954 |
| ANDROID 1010mg · Tablet | Methyltestosterone | Estados Unidos | No comercializado | 1981 |
| ANDROID 55MG · Tablet | Methyltestosterone | Estados Unidos | No comercializado | 1981 |
| ANDROID-F10mg · Tablet | Fluoxymesterone | Estados Unidos | No comercializado | 1981 |
| BENDOPA100mg | 250mg | 500mg · Capsule | Levodopa | Estados Unidos | No comercializado | |
| BENOQUIN20% · Cream | Monobenzone | Estados Unidos | No comercializado | 1952 |
| BENZAMYCIN5%; 3% · GEL | Benzoyl peroxide, Erythromycin | Estados Unidos | Comercializado | 1984 |
| BONTRIL105mg · Capsule, extended release | Phendimetrazine | Estados Unidos | No comercializado | 1982 |
| COLAZAL750mg · Capsule | Balsalazide | Estados Unidos | Comercializado | 2000 |
| CUPRIMINE125mg | 250mg · Capsule | Penicillamine | Estados Unidos | Comercializado | 1970 |
| DALMANE15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Capsule | Flurazepam | Estados Unidos | No comercializado | 1970 |
| DERMATOP0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Ointment | Prednicarbate | Estados Unidos | No comercializado | 1991 |
| DERMATOP E EMOLLIENT0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Cream | Prednicarbate | Estados Unidos | No comercializado | 1993 |
| DIPHENHYDRAMINE HYDROCHLORIDE25mg | 50mg · Capsule | Diphenhydramine | Estados Unidos | No comercializado | 1972 |
| ELDECORT1% | 2.5% · Cream | Hydrocortisone | Estados Unidos | No comercializado | |
| FLUOXYMESTERONE10mg | 2mg | 5mg · Tablet | Fluoxymesterone | Estados Unidos | No comercializado | 1983 |
| GIAZO1.1GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Balsalazide | Estados Unidos | No comercializado | 2012 |
| GRIFULVIN V500mg · Tablet | Griseofulvin, Microsize | Estados Unidos | No comercializado | 1980 |
| GRIFULVIN V125MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Suspension | Griseofulvin, Microsize | Estados Unidos | No comercializado | 1984 |
| GRIFULVIN V125MG | 250MG | 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 500MG · Tablet | Griseofulvin, Microcrystalline | Estados Unidos | No comercializado | 1971 |
| HYTONE1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 2.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Cream | Hydrocortisone | Estados Unidos | No comercializado | 1972 |
| HYTONE1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 2.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Lotion | Hydrocortisone | Estados Unidos | No comercializado | 1972 |
| LEVO-DROMORAN2mg/ml · Injectable | Levorphanol | Estados Unidos | No comercializado | 1953 |
| LEVO-DROMORAN2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Levorphanol | Estados Unidos | No comercializado | 1953 |
| LIBRELEASE30mg · Capsule, extended release | Chlordiazepoxide | Estados Unidos | No comercializado | 1983 |
Dónde es titular o fabricante de medicamentos, y cuántos están vigentes.
| País | Medicamentos | Vigentes | Anteriores | Empresas |
|---|---|---|---|---|
| Canadá | 120 | 0 | 120 | EmpresasTodos los medicamentos |
| Brasil | 54 | 0 | 54 | EmpresasTodos los medicamentos |
| Estados Unidos | 44 | 44 | 0 | EmpresasTodos los medicamentos |
| Arabia Saudí | 4 | 4 | 0 | EmpresasTodos los medicamentos |
Los grupos ATC a los que pertenecen la mayoría de sus medicamentos, de mayor a menor.
Los principios activos presentes en la mayoría de sus medicamentos.
Cómo lo escriben los registros, normalizado: sin forma jurídica, tildes ni mayúsculas.
Recopilado por Prognia a partir de los registros públicos de medicamentos y empresas que aparecen abajo. No se usan logotipos.
Prognia forma los grupos a partir de los nombres que publican las autoridades reguladoras y de los vínculos entre empresas; no son una estructura societaria oficial.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licencia: Public domain (U.S. Government work)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licencia: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, https://dados.anvisa.gov.br/dados/CONSULTAS/EMPRESA_FISCALIZACAO_PRODUTO/TA_CONSULTA_CBPF_MEDICAMENTO_DETALHE.CSV; source modified Fri, 15 May 2026 07:52:35 GMT; acquired 2026-10-18T08:23:43.211112+00:00; original factual values retained, no endorsement.
Licencia: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licencia: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Agência Nacional de Vigilância Sanitária (Anvisa), DATAVISA open-data register; source modification 2026-10-07, acquired 2026-10-07 UTC.
Licencia: Brazil federal open-data reuse, Decreto 8777/2016, consolidated article 4 as amended by Decreto 9903/2019
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licencia: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licencia: Open Government Licence Canada
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licencia: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Informa de un error o solicita la retiradaLas correcciones de la propia empresa son bienvenidas.
Mantenga correctos los medicamentos de Valeant en Prognia, vea cómo los consultan los profesionales y responda a lo que preguntan. Una llamada de 20 minutos, en inglés.
Reservar una llamadaGrupos farmacéuticos conocidos, cada uno con todas sus empresas.